Published in Brain Res Dev Brain Res on March 12, 1999
Biosocial studies of antisocial and violent behavior in children and adults: a review. J Abnorm Child Psychol (2002) 2.71
Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ Health Perspect (2004) 2.25
Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ Health Perspect (2003) 1.44
Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice. J Physiol (2002) 1.08
Perinatal environmental tobacco smoke exposure in rhesus monkeys: critical periods and regional selectivity for effects on brain cell development and lipid peroxidation. Environ Health Perspect (2006) 1.07
The Role of Nicotine in the Effects of Maternal Smoking during Pregnancy on Lung Development and Childhood Respiratory Disease. Implications for Dangers of E-Cigarettes. Am J Respir Crit Care Med (2016) 0.91
Alterations in cholinergic sensitivity of respiratory neurons induced by pre-natal nicotine: a mechanism for respiratory dysfunction in neonatal mice. Philos Trans R Soc Lond B Biol Sci (2009) 0.89
The role of infection and inflammation in sudden infant death syndrome. Immunopharmacol Immunotoxicol (2009) 0.84
Endogenous inhibition of the trigeminally evoked neurotransmission to cardiac vagal neurons by muscarinic acetylcholine receptors. J Neurophysiol (2010) 0.84
The Yin and Yang of Nicotine: Harmful during Development, Beneficial in Adult Patient Populations. Front Pharmacol (2012) 0.80
Sudden Infant Death Syndrome - Role of Trigeminocardiac Reflex: A Review. Front Neurol (2016) 0.77
Differential responses of hippocampal neurons and astrocytes to nicotine and hypoxia in the fetal guinea pig. Neurotox Res (2012) 0.75
Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol Appl Pharmacol (1998) 2.58
Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol Appl Pharmacol (1995) 2.47
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res Dev Brain Res (2001) 1.90
Chlorpyrifos interferes with cell development in rat brain regions. Brain Res Bull (1997) 1.88
Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology (1998) 1.83
Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Brain Res Dev Brain Res (1998) 1.60
Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res Dev Brain Res (2000) 1.58
Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect (2001) 1.57
An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res (2000) 1.51
Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull (1998) 1.48
Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Brain Res Dev Brain Res (1999) 1.48
Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res (1999) 1.40
Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res (2001) 1.39
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res (2001) 1.36
Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in cell replication and differentiation. Brain Res (2000) 1.34
Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J Physiol (1985) 1.32
Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res (2002) 1.29
Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat (2000) 1.25
Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res (2001) 1.21
Is oxidative stress involved in the developmental neurotoxicity of chlorpyrifos? Brain Res Dev Brain Res (2000) 1.20
Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J Dev Physiol (1988) 1.13
Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J Pharmacol Exp Ther (1989) 1.13
Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. Teratology (1997) 1.10
Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Brain Res Dev Brain Res (2002) 1.09
Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull (1989) 1.09
Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res (2000) 1.06
Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther (1998) 1.05
Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Brain Res Dev Brain Res (2000) 1.05
Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull (1995) 1.05
Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther (2007) 1.05
Ontogeny of adrenomedullary responses to hypoxia and hypoglycemia: role of splanchnic innervation. Brain Res Bull (1986) 1.05
Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res (2000) 1.02
Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr Res (1988) 1.02
Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest (1994) 1.01
Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Brain Res Dev Brain Res (2001) 0.97
Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry (1997) 0.97
Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding. Neurotoxicol Teratol (1993) 0.95
Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol (1997) 0.95
Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res (2002) 0.94
Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther (1987) 0.93
Ontogeny of histaminergic neurotransmission in the rat brain: concomitant development of neuronal histamine, H-1 receptors, and H-1 receptor-mediated stimulation of phospholipid turnover. J Neurochem (1981) 0.93
Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. J Dev Physiol (1992) 0.92
Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther (1988) 0.92
Ontogeny of cardiac beta-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. J Mol Cell Cardiol (1999) 0.90
Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res (1991) 0.90
Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther (1999) 0.89
Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology (1993) 0.89
Cardiac alpha-adrenergic receptor expression is regulated by thyroid hormone during a critical developmental period. J Mol Cell Cardiol (1996) 0.89
Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Res Dev Brain Res (1996) 0.88
Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res (2000) 0.88
Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Brain Res Dev Brain Res (1999) 0.88
Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc Natl Acad Sci U S A (1990) 0.88
Non-neurogenic mechanism for reserpine-induced release of catecholamines from the adrenal medulla of neonatal rats: possible modulation by opiate receptors. Neuroscience (1982) 0.87
Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. Neuroscience (1981) 0.87
Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity. Biol Neonate (1992) 0.86
Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr Res (1994) 0.86
Beta-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Brain Res Dev Brain Res (2001) 0.86
Ontogeny of (--)-[3H]norepinephrine uptake properties of synaptic storage vesicles of rat brain. Brain Res (1978) 0.86
Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated cell signaling in brain and heart of neonatal rats. Brain Res (2001) 0.86
Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor down-regulation. Pediatr Res (1996) 0.86
Prenatal nicotine exposure impairs beta-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull (1990) 0.85
Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res Bull (1993) 0.84
Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res (1997) 0.84
Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res (1990) 0.84
Non-neurogenic adrenal catecholamine release in the neonatal rat: exocytosis or diffusion? Brain Res (1986) 0.84
Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to beta-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol (1992) 0.84
Stimulation of ornithine decarboxylase by histamine or norepinephrine in brain regions of the developing rat: evidence for biogenic amines as trophic agents in neonatal brain development. Life Sci (1983) 0.83
Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Brain Res Dev Brain Res (1992) 0.83
Histamine stimulates brain phospholipid turnover through a direct, H-1 receptor-mediated mechanism. Life Sci (1980) 0.83
Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Brain Res Dev Brain Res (1998) 0.83
Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins. Neurotoxicol Teratol (1993) 0.83
Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. Brain Res Bull (1986) 0.83
Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the pre-weanling rat. Br J Pharmacol (1979) 0.82
Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull (1998) 0.82
Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems. Life Sci (1984) 0.82
Rat brain synaptic vesicles: uptake specificities of [3H]norepinephrine and [3H]serotonin in preparations from whole brain and brain regions. J Neurochem (1978) 0.82
Differential development of cholinergic nerve terminal markers in rat brain regions: implications for nerve terminal density, impulse activity and specific gene expression. Brain Res (1993) 0.82
Thyroid hormone differentially regulates cellular development in neonatal rat heart and kidney. Teratology (1992) 0.82
Combining 'caged-dopamine' photolysis with fast-scan cyclic voltammetry to assess dopamine clearance and release autoinhibition in vitro. J Neurosci Methods (1996) 0.81
Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain. Brain Res Dev Brain Res (1997) 0.81
Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues. Teratology (1991) 0.81
Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol (1994) 0.81
Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci (1990) 0.81
Sex-related spatial learning differences after prenatal cocaine exposure in the young adult rat. Neurotoxicology (1993) 0.80
Persistent c-fos induction by nicotine in developing rat brain regions: interaction with hypoxia. Pediatr Res (1999) 0.80
Acute and chronic effects of nicotine on synthesis and storage of catecholamines in the rat adrenal medulla. Life Sci (1975) 0.80
High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann N Y Acad Sci (1996) 0.80
Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat. Brain Res Bull (1991) 0.80
Neonatal central catecholaminergic lesions with intracisternal 6-hydroxydopamine: effects on development of presynaptic and postsynaptic components of peripheral sympathetic pathways and on the ornithine decarboxylase/polyamine system in heart, lung and kidney. J Pharmacol Exp Ther (1988) 0.80
Dexamethasone treatment in utero enhances neonatal cholinergic nerve terminal development in rat brain. Res Commun Chem Pathol Pharmacol (1993) 0.80
Chronic prenatal nicotine exposure sensitizes rat brain to acute postnatal nicotine challenge as assessed with ornithine decarboxylase. Life Sci (1991) 0.79
Adolescent nicotine exposure alters cardiac autonomic responsiveness: beta-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. Brain Res (2000) 0.79
Fetal terbutaline exposure causes selective postnatal increases in cerebellar alpha-adrenergic receptor binding. Life Sci (1990) 0.79
Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. J Pharmacol Exp Ther (1982) 0.79
Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover. J Pharmacol Exp Ther (1982) 0.79